Intervention Protocol

You have free access to this content

Rituximab for treating inhibitors in children with hemophilia

  1. Yi Liu1,2,3,
  2. Lingli Zhang1,2,*,
  3. Cristina Santoro4,
  4. Jie Song1,2,3,
  5. Armando Rodriguez5,
  6. Li Wang6

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 30 OCT 2013

Assessed as up-to-date: 23 OCT 2013

DOI: 10.1002/14651858.CD010810


How to Cite

Liu Y, Zhang L, Santoro C, Song J, Rodriguez A, Wang L. Rituximab for treating inhibitors in children with hemophilia (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010810. DOI: 10.1002/14651858.CD010810.

Author Information

  1. 1

    West China Second University Hospital, Sichuan University, Department of Pharmacy, Evidence-based Pharmacy Center, Chengdu, Sichuan, China

  2. 2

    Sichuan University, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Chengdu, China

  3. 3

    Sichuan University, West China Second University Hospital, Chengdu, China

  4. 4

    Sapienza University of Rome, Department of Hematology and Cellular Biotechnology, Rome, Italy

  5. 5

    Association for the Promotion of Multimedia Education, Zagreb, Croatia

  6. 6

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chengdu, Sichuan, China

*Lingli Zhang, zhlingli@sina.com.

Publication History

  1. Publication Status: New
  2. Published Online: 30 OCT 2013

SEARCH